INC forms ePRO partnership with invivodata

By Nick Taylor

- Last updated on GMT

Related tags: Epro

INC Research is partnering with invivodata to add ePRO to its offering, selecting the eClinical firm over its competitors in part because it understands the “aggressive” approach the CRO takes.

Alistair Macdonald, executive vice president, Strategic Development at INC, explained to Outsourcing-Pharma that the contract research organisation (CRO) has an aggressive, process orientated approach.

invivodata understands this way of working and this was a factor in selecting it as a partner for electronic patient reported outcomes (ePRO). Formalising the ePRO partnership will reassure clients that INC knows how the product works and information integrates into the database.

Furthermore, the close relationship between INC and invivodata allows the CRO to reach out to people at the eClinical firm if an issue arises.

Related news

Show more

Related products

show more

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Baxter’s Oncology Contract Manufacturing

Baxter’s Oncology Contract Manufacturing

Baxter BioPharma Solutions | 29-Aug-2018 | Product Brochure

Baxter BioPharma Solutions’ FOYA award-winning facility in Halle/Westfalen, Germany, offers state-of-the-art parenteral cGMP manufacturing at one location,...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars